Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2019 Mar 5;10:352. doi: 10.3389/fmicb.2019.00352

Alterations of the Mice Gut Microbiome via Schistosoma japonicum Ova-Induced Granuloma

Yanqing Zhao 1,2,, Shuguo Yang 1,2,, Bei Li 1,2, Wei Li 3, Jue Wang 1,2, Zongyun Chen 1,2, Jing Yang 1,2, Huabing Tan 1,2, Jian Li 1,2,*
PMCID: PMC6411663  PMID: 30891012

Abstract

Schistosomiasis, also called bilharziasis, is a neglected tropical disease induced by Schistosoma spp. that causes hundreds of millions of infections. Although Schistosoma ova-induced granulomas commonly cause inflammation, hyperplasia, ulceration, micro abscess formation, and polyposis, the role of the egg granuloma on the gut microbiome remains unclear. To explore the role, gut microbial communities in mice infected with Schistosoma japonicum were surveyed. Female C57BL/6 and BALB/c mice were exposed to cercariae of S. japonicum for 45 and 65 days and then sacrificed. Intestinal contents and feces were collected, DNA was extracted, and high-throughput 16S rRNA gene-based pyrosequencing was used to provide a comparative analysis of gut microbial diversity. The intestinal mucosal tissues were also examined. Histopathologic analysis demonstrated that the basic structure of the colonic mucosa was damaged by ova-induced granuloma. Regarding the gut microbiome, 2,578,303 good-quality sequences were studied and assigned to 25,278 Operational Taxonomic Units (OTUs) at a threshold of 97% similarity. The average number of OTUs for C57BL/6 and BALB/c were 545 and 530, respectively. At the phylum level, intestinal microbial communities were dominated by Firmicutes, Bacteroidetes, Proteobacteria, and Verrucomicrobia. Infection with S. japonicum modified bacterial richness in the fecal associated microbiota. Exposure significantly modified bacterial community composition among different groups. At the phylogenetic levels, LEfSe analysis revealed that several bacterial taxa were significantly associated with the S. japonicum-infected mice. The present results suggest that egg granulomas in the intestine influence differentiation of the gut microbial community under pathophysiological conditions. This result suggests that intestinal microbiome-based strategies should be considered for early diagnosis, clinical treatment, and prognosis evaluation of schistosomiasis.

Keywords: Schistosoma japonicum, egg granulomas, gut microbiome, 16S rRNA, operational taxonomic units

Introduction

Schistosomiasis, formerly called snail fever, is caused by the genus Schistosoma, particularly S. mansoni, S. haematobium, and S. japonicum (McManus et al., 2018), and it is considered a global neglected tropical diseases (NTDs) (McManus et al., 2018). As the second-most socioeconomically devastating parasitic disease after malaria, schistosomiasis causes hundreds of millions of infections in certain parts of Asia, Africa, and Latin America (Ross et al., 2002) and threatens the animal husbandry economy worldwide.

Eggs are regarded as the main pathogenic factor of schistosomiasis, and ova-granulomas develop in the tissues and organs of human and reservoir hosts (Schwartz and Fallon, 2018). The greatest number of egg granulomas of schistosomiasis develop at locations of maximal egg accumulation, including the intestine, liver and genitourinary tract (Ross et al., 2002). Diarrhea is common, as is occult blood in the feces. Eggs retained in the gut wall induce inflammation, hyperplasia, ulceration, micro abscess formation, and polyposis, but little is known about the relationship between schistosome infection and the composition of the gut microbiome. Fortunately, a recent study showed fecal microbiome differences between S. haematobium infected and uninfected children (Kay et al., 2015). Furthermore, two independent studies illustrated that S. mansoni infection is associated with an altered gut microbiome (Jenkins et al., 2018; Schneeberger et al., 2018). However, the role that egg granulomas of S. japonicum play in the gut microbiome of the mammalian host is still unclear.

To explore the possible role of S. japonicum ova-induced granulomas on the gut microbiome, we used a murine model of schistosomiasis, generated by challenge with cercaria of S. japonicum. The objectives of this study were: (1) to characterize the microbiota in the gut after damage from S. japonicum ova-induced granulomas and (2) to identify bacterial taxa that are associated with S. japonicum infection in different mouse strains and different disease phases.

Materials and Methods

Parasite Preparation and Animal Studies

Female C57BL/6 and BALB/c mice (24 of each inbred strain) of 6 to 8 weeks of age were randomly divided into the following groups: Control (Ctrl), Acute phase (AP), and Chronic phase (CP). Each group of animals was housed in separate cages, and all mice were maintained in a 12/12 h light/dark cycle at the same temperature (25 ± 1.5°C, 50 ± 5% relative humidity controlled by automatic heating and ventilation devices) and fed standard mouse chow (purchased from HNSJA Co., Ltd., Changsha of China) and pure water (Zhao et al., 2016).

The cercariae of S. japonicum (Chinese strain) were obtained from freshwater snails (Oncomelania hupensis) that were purchased from the Jiangsu Institute of Parasitic Diseases, Eastern China. In the AP and CP groups, mice were each challenged with 35 ± 1 cercariae. At 42 days post-infection, feces were examined to confirm the infection. At 8 weeks post infection, the host entered the chronic infection stage (Ferrari and Moreira, 2011; Seki et al., 2012; Chen et al., 2017). Under sterile conditions, mice in the Ctrl and AP groups were sacrificed at day 45, and CP mice were sacrificed on day 65.

Pathologic Analysis

For pathologic analysis, samples of the liver, spleen and intestine were obtained. The tissues were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 4.0 μm, and stained with hematoxylin and eosin for microscopic observation (six tissue samples for each group and three slices for each tissue). All procedures were performed without serious complications. The slides were interpreted under a light microscope (Olympus, Tokyo, Japan). The initial macroscopic diagnosis was made by the parasitologists, and the final diagnosis was confirmed histopathologically.

Intestinal Content Sampling and DNA Extraction

The feces and intestinal contents were collected under sterile conditions. In brief, on the day of sacrifice, the fresh feces were collected at the time of defecation by scooping the feces into a sterile 15 ml centrifuge tube. For collection of intestinal contents, the intestine was cut into two fragments at the ileocecal junction. The contents were eluted from both fragments of the intestine with 10 ml of sterile normal saline and collected in 15 ml tubes. The tubes were centrifuged at 4,000 rpm for 10 min, and the supernatant was discarded. The feces and intestinal contents from the same mice were mixed and frozen in liquid nitrogen for 15 s and stored at −80°C in the laboratory before shipment.

Samples were packaged with 15 kg dry ice and sent to a company (Novogene Bioinformatics Technology Co., Ltd. in Tianjin, China) where the samples were stored at −80°C until DNA extraction. Total bacterial DNA was extracted from approximately 400–600 mg of each sample using a PowerFecal™ DNA Isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) according to the manufacturer's instructions, and was stored at −80°C before further analysis. The DNA concentration and purity was checked on 1% agarose gel, and the DNA was diluted to a 1 ng/μl working stock.

Amplification and Sequencing

The 16S rRNA genes of the distinct V4 region (515-806, 392 bp) were amplified using specific primers. Briefly, DNA was amplified by using the 515F and 806R primer set (515F: 5′-GTG CCA GCM GCC GCG GTA A-3′; 806R: 5′- GGA CTA CHV GGG TWT CTA AT-3′), which targets the V4 region of bacterial 16S rDNA, with the reverse primer containing a 6-bp error-correcting barcode unique to each sample. PCR was performed using the Phusion® High-Fidelity PCR Master Mix with GC Buffer containing Taq DNA polymerase premix (New England Biolabs LTD., Beijing, China). The reaction occurred under the following conditions: 94°C for 3 min (1 cycle); 94°C for 45 s, 50°C for 60 s, 72°C for 90 s (35 cycles), and a final step of 72°C for 10 min. The same volume of 1 × loading buffer (containing SYB green) was mixed with the PCR products and underwent electrophoresis on a 2% agarose gel for detection. Samples with a bright main strip between 400 and 450 bp were chosen for further experiments. PCR products were mixed in equi-density ratios and purified by using the QIAquick Gel Extraction Kit (QIAGEN, Dusseldorf, Germany).

Sequencing libraries were generated using the TruSeq® DNA PCR-Free Sample Preparation Kit (Illumina, San Diego CA, USA) following the manufacturer's recommendations, and index codes were added. The library quality was assessed on the Qubit@ 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 system. Subsequently, the library was sequenced on an Illumina HiSeq 2500 platform, and 250 bp paired-end reads were generated.

Data Analysis

Sample paired-end reads were merged by using FLASH V1.2.7 (Magoc and Salzberg, 2011). Quality filtering of the raw sequences was performed with QIIMEV1.7.0. The chimera sequences were detected using the UCHIME algorithm (Edgar et al., 2011) and were removed (Haas et al., 2011). Then, the effective sequences were obtained. Sequences analysis was performed by using UPARSE software package (Edgar, 2013). Sequences with ≥ 97% similarity were assigned to the same OTUs. A representative sequence for each OTU was screened for further annotation. For each representative sequence, the GreenGenes Database (DeSantis et al., 2006) was used based on the RDP classifier Version 2.2 (Wang et al., 2007) algorithm to annotate taxonomic information. Multiple sequence alignments were conducted using the MUSCLE software (Edgar, 2004). OTU abundance information was normalized using a standard of sequence numbers corresponding to the sample with the fewest sequences. Subsequent analyses of alpha diversity and beta diversity were all performed based on this output normalized data.

The alpha diversity in each sample was estimated by Observed species, Chao1, Shannon, and Good-coverage. All these indices in the samples were calculated with QIIME and displayed with R software (Version 2.15.3). Beta diversity analysis was used to evaluate differences in samples regarding bacterial community composition. Beta diversity on (un)weighted UniFrac was calculated by QIIME. Principal Coordinates Analysis (PCoA) was displayed using the WGCNA package, stat packages, and ggplot2 package in R software. Unweighted Pair-group Method with Arithmetic Means (UPGMA) Clustering was performed as a type of hierarchical clustering method to interpret the distance matrix using average linkage and was conducted by QIIME. A Wilcox rank-sum test was used as a significance test of alpha diversity and beta diversity differences between sample groups. Linear discriminant analysis coupled with effect size (LEfSe) was performed to identify the bacterial taxa differentially represented between groups at the genus or higher taxonomy levels.

Statistical Analysis

Statistical analysis for the gut microbiome in mice was performed as described above. For all other experiments, the data were validated and analyzed using Statistical Package for Social Science (SPSS) for Windows version 17.0 (SPSS Inc., Chicago, IL, USA). To test whether there was a significant difference between two or more groups of sampling units in C57BL/6 and BALB/c mice, Analysis of Similarities (ANOSIM), and Multiple Response Permutation Procedure (MRPP) were used (Sickle, 1997). Statistical significance was defined as a P-value less than 0.05.

Results

General Information and Pathological Analysis

At Day 0, mice in the AP and CP groups were infected with cercariae of S. japonicum. At Day 42, mature eggs containing live miracidium of S. japonicum were detected in the feces by microscopy, confirming successful infection (Figure 1). Compared with the Ctrl group, the morphology of the intestine, liver and spleen and the weight of the body, liver, and spleen were dramatically altered for both C57BL/6 and BALB/c infected mice (Figure 1; Supplementary Figure 1). Furthermore, intestinal epithelial edema, inflammation, necrosis, and liver nodules were observed in the infected groups (Figure 1; Supplementary Figure 1). Compared to the AP group of C57BL/6 and BALB/c mice (C57.AP and BA.AP), the intestinal diameter in the CP group of both mouse strains was significantly increased (Figure 1). This usually results from intestinal obstruction, ulcer formation, hemorrhage, and perforation. The main pathomorphological change of the intestinal mucosa was the S. japonicum ova-induced granuloma (Figure 1). Further pathological analysis demonstrated that egg granulomas were mainly detected in the submucosa, and only a small number of egg granulomas was found in the muscle layers in C57.AP and BA.AP. In the CP group, the egg granulomatous reactions were not only distributed in submucosa, but numerous egg granulomas had circulated and destroyed muscle layers (Figure 1). Compared to the AP group, more neutrophils infiltrated around the egg granuloma in the CP group (Figure 1).

Figure 1.

Figure 1

Microscopy visualization and pathological analysis of C57BL/6 and BALB/c mice with Schistosoma japonicum infection. For C57BL/6 and BALB/c mice, feces from groups Ctrl and AP at day 45 and CP on day 65 were obtained. The liver, spleen, intestine and feces from groups Ctrl and AP at day 45 and CP on day 65 were obtained. The blue arrow represents an S. japonicum egg. The red circle represents a small intestinal lesion. The egg granulomas of S. japonicum from the intestinal mucosa are indicated by the black frame.

Overview of Sequencing Analysis

One sample from the CP group of C57BL/6 mice was discarded due to low quality so that a total of 23 samples (8 Ctrl, 8 AP, 7 CP) from C57BL/6 mice and 24 samples (8 Ctrl, 8 AP, 8 CP) from BALB/c mice were finally collected for 16S rRNA sequencing. In total, 2,730,325 raw sequences from 47 samples were generated, and the number of sequences varied from a minimum of 31,688 sequences obtained in C57BL/6 mice during the chronic phase (CCP4), to a maximum of 69,693 sequences obtained during the chronic phase in BALB/c mice (BCP2, Table 1). The mean number of sequences per sample was 58,092 ± 9,688 (standard deviation, SD). The species accumulation curves indicated that species richness representation in all samples had approached the plateau phase, and it was unlikely that more observed species would be detected without additional samples (Supplementary Figure 2A). Similarly, the rarefaction curves demonstrated that species representation in individual specimens had approached a saturation number of the observed species, and it did not seem as though more OTUs would be obtained with additional sequencing efforts (Supplementary Figure 2B). After sequence trimming, quality filtering and checking for chimeras, a total of 2,578,303 high-quality sequences remained. The number of effective tags varied from a minimum of 26,199 tags obtained in BCP5 to a maximum of 66,089 tags obtained in BCP2, with an average length of 253 bases (Table 1). The GC content in these samples ranged from 52.76 to 55.46%, and the average was 54.26 ± 0.61% (SD). At a threshold of 97% identity, these high-quality sequences were assigned to 25,278 OTUs. Each sample had 54,858 sequences, 538 OTUs, and 469 observed species on average (Table 1). The results showed that the bacteria belonged to 16 phyla, 33 classes, 60 orders, 109 families, and 240 genera.

Table 1.

Operational taxonomic unit (OTU)-based diversity indexes in mice gut samples during infection.

Sample name Group Raw PE(#) Raw Tags(#) Clean Tags(#) Effective Tags(#) Base (nt) Q30 GC (%) Effective (%) OTUs Observed species shannon chao1 Goods coverage
CC1 C57.Ctrl 62,246 61,755 61,224 59,312 14,985,918 98.98 54.39 95.29 570 486 6.292 525.276 0.997
CC2 53,227 52,890 52,432 50,680 12,811,999 99.00 53.92 95.21 591 519 5.758 636.404 0.996
CC3 40,057 39,756 39,424 37,849 9,566,440 98.84 54.29 94.49 549 506 6.279 577.400 0.997
CC4 57,482 57,138 56,704 54,690 13,826,825 98.97 52.90 95.14 576 494 4.602 559.632 0.997
CC5 64,641 64,143 63,561 61,700 15,591,329 98.92 54.72 95.45 587 509 6.441 567.263 0.997
CC6 65,626 65,124 64,641 62,730 15,856,322 98.97 53.92 95.59 575 496 5.627 539.359 0.997
CC7 68,762 68,300 67,711 66,001 16,675,191 98.97 54.26 95.98 540 460 5.565 531.143 0.997
CC8 53,049 52,704 52,226 50,684 12,808,063 98.96 53.86 95.54 555 505 6.003 602.020 0.996
CAP1 C57.AP 57,887 57,453 56,960 55,080 13,916,102 98.97 53.94 95.15 539 471 5.644 508.143 0.997
CAP2 57,589 57,117 56,602 54,808 13,836,112 98.86 55.15 95.17 577 502 6.349 543.714 0.997
CAP3 67,559 67,036 66,465 64,671 16,334,529 98.89 55.09 95.73 561 476 5.343 522.480 0.997
CAP4 61,722 61,241 60,655 58,670 14,813,426 98.89 54.43 95.06 540 438 5.703 508.288 0.997
CAP5 69,494 69,009 68,480 65,657 16,599,279 98.99 54.94 94.48 500 394 4.582 489.192 0.996
CAP6 52,343 51,960 51,348 50,027 12,695,014 98.95 53.91 95.58 555 516 6.430 581.632 0.997
CAP7 63,355 62,869 62,350 59,812 15,118,445 98.95 54.20 94.41 591 519 6.652 580.158 0.997
CAP8 45,988 45,595 45,139 44,180 11,159,420 98.79 55.46 96.07 511 462 5.205 513.776 0.997
CCP1 C57.CP 62,461 62,036 61,563 58,349 14,750,706 98.99 52.76 93.42 520 436 4.819 507.400 0.997
CCP2 64,117 63,679 63,227 61,538 15,555,415 99.02 54.55 95.98 503 420 4.558 465.310 0.997
CCP3 68,435 68,008 67,543 65,977 16,681,493 99.04 54.52 96.41 480 378 3.517 473.020 0.996
CCP4 31,688 31,426 31,166 30,402 7,682,806 98.8 53.85 95.94 447 405 5.415 438.549 0.998
CCP5 66,501 65,961 65,399 63,865 16,163,855 98.88 55.42 96.04 543 455 5.084 523.018 0.997
CCP6 65,609 64,987 64,437 62,111 15,702,213 98.86 53.69 94.67 569 480 5.868 528.456 0.997
CCP7 58,799 58,334 57,773 56,234 14,216,112 98.82 54.37 95.64 568 498 6.607 552.808 0.997
BC1 BA.Ctrl 61,431 61,035 60,504 59,027 14,911,767 98.93 53.82 96.09 507 424 4.867 476.667 0.997
BC2 69,175 68,624 68,059 66,014 16,687,060 98.90 54.11 95.43 564 485 6.350 550.553 0.997
BC3 55,838 55,480 54,999 53,404 13,503,677 98.96 54.48 95.64 557 475 5.690 531.269 0.997
BC4 34,463 34,177 33,851 32,682 8,262,139 98.81 54.35 94.83 503 466 6.546 498.283 0.998
BC5 68,559 68,067 67,476 65,208 16,484,146 98.93 53.75 95.11 543 479 6.204 516.967 0.997
BC6 67,202 66,742 66,122 64,381 16,277,889 98.88 54.57 95.80 551 482 6.109 518.491 0.997
BC7 60,723 60,318 59,800 58,046 14,673,119 98.92 53.81 95.59 536 461 5.752 530.081 0.997
BC8 53,008 52,685 52,264 50,965 12,881,134 98.99 54.35 96.15 506 455 6.093 540.213 0.997
BAP1 BA.AP 64,636 64,153 63,498 61,339 15,498,643 98.85 53.76 94.90 571 503 6.926 572.081 0.997
BAP2 53,235 52,842 52,374 49,906 12,609,458 98.91 54.29 93.75 571 511 6.497 588.233 0.997
BAP3 62,268 61,778 61,226 57,675 14,564,826 98.91 54.07 92.62 591 522 6.744 570.300 0.997
BAP4 53,458 52,984 52,468 50,340 12,707,679 98.83 54.29 94.17 559 520 6.819 578.000 0.997
BAP5 67,079 66,651 66,034 60,520 15,296,635 98.91 53.62 90.22 558 468 4.587 521.644 0.997
BAP6 62,581 62,093 61,573 55,425 14,012,600 98.95 53.63 88.57 499 421 5.407 487.279 0.997
BAP7 60,239 59,815 59,234 57,919 14,635,439 98.85 54.48 96.15 571 498 6.510 541.596 0.997
BAP8 50,375 49,933 49,497 47,460 11,996,688 98.91 54.76 94.21 567 522 6.243 588.750 0.997
BCP1 BA.CP 34,534 34,279 33,957 33,028 8,344,957 98.77 55.35 95.64 494 455 5.671 484.057 0.998
BCP2 69,693 69,233 68,638 66,089 16,709,132 98.97 52.77 94.83 487 420 4.053 515.136 0.996
BCP3 55,751 55,309 54,806 53,346 13,476,296 98.90 54.86 95.69 504 438 6.555 474.849 0.998
BCP4 58,121 57,687 57,190 55,061 13,914,775 98.96 54.44 94.74 473 408 5.030 442.528 0.998
BCP5 40,336 38,617 26,718 26,199 6,617,591 98.71 54.52 64.95 425 390 5.284 436.406 0.998
BCP6 54,409 54,016 53,599 52,406 13,247,321 98.87 54.92 96.32 542 469 5.091 529.768 0.997
BCP7 63,040 61,192 60,283 57,207 14,560,230 98.71 54.19 90.75 524 465 5.587 522.130 0.997
BCP8 51,534 51,156 50,678 49,629 12,539,299 98.79 54.61 96.30 528 485 6.615 555.660 0.997
Total 2,730,325 2,707,387 2,671,878 2,578,303 651,759,514 4,648.43 2,550.34 4,430.89 25,278 22,047 269.573 24,845.382 46.860
Max 69,693 69,233 68,638 66,089 16,709,132 99.04 55.46 96.41 591 522 6.926 636.404 0.998
Mini 31,688 31,426 26,718 26,199 6,617,591 98.71 52.76 64.95 425 378 3.517 436.406 0.996
Average 58,092 57,604 56,848 54,858 13,867,224 98.90 54.26 94.27 538 469 5.736 528.625 0.997
SD 9,688 9,669 10,216 9,776 2,471,997 0.08 0.61 4.64 39 39 0.788 43.734 0.000

C57 and BA represent C57BL/6 and BALB/c mice, respectively; Ctrl, AP and CP represent Group Control, Acute phase and Chronic phase, respectively; Max, Mini and SD stand for maximum value, minimum value and Standard deviation, respectively.

In total, the trends in OTU numbers from the Ctrl to the CP group were different between C57BL/6 and BALB/c mice. For C57BL/6 mice, the OTU number rapidly decreased immediately after infection compared to the Ctrl (Table 1). In contrast, the OTU trends in BALB/c mice increased to a peak in AP and then decreased to a valley in CP. Detailed characteristics of each sample are listed in Table 1. Venn diagram was created to compare the similarities and differences among the communities in the different groups and samples (Supplementary Figure 3). For individual samples, the maximum, minimum and mean unique OTUs were 36 in BC2, 3 in CCP3, and 15, respectively (Supplementary Figure 3).

Bacterial Community Composition and Structure Succession Analysis

At the phylum level, the intestinal microbial communities in all samples were dominated by Firmicutes (58.87%), Bacteroidetes (18.67%), Proteobacteria (13.80%), and Verrucomicrobia (6.05%) (Figures 2A,B). For individual groups, the dominant phylum had various patterns. Verrucomicrobia was significantly more abundant in C57.AP than in BA.AP (P = 0.011). In contrast, Firmicutes was significantly more abundant in the AP group of BALB/c than in C57BL/6 mice (P = 0.020). Analogously, Proteobacteria were present at a > 4-fold higher abundance in C57.CP than in BA.CP (P = 0.002). In contrast, Verrucomicrobia were present at a > 4-fold higher abundance in BA.CP than in C57.CP (P = 0.060). Several of the most abundant taxa from the Ctrl and CP groups gradually increased, particularly in BALB/c mice (Figure 2B). However, the percentage of dominant taxa was dramatically decreased during infection. As the dominant taxon, the abundance of Firmicutes gradually decreased following infection. The abundance of Bacteroidetes dramatically increased on day 45 post-infection, but then decreased from day 65 onwards. The abundance of Proteobacteria gradually increased on day 45 and dramatically increased on day 65 post-infection in C57BL/6 mice (Figure 2A), while the abundance of Proteobacteria throughout the infection had little change in BALB/c mice (Figure 2B).

Figure 2.

Figure 2

Variation of bacterial community structure. The relative abundance of bacterial phyla and families present in the gut of C57BL/6 and BALB/c mice. Data shown represent the top 10 most abundant phyla and families, whereas low abundance and unclassified OTUs were grouped in “Other.” Sample names refer to samples as described in Table 1. (A) Bacterial community structure variation at the phylum level in C57BL/6 mice; (B) Bacterial community structure variation at the phylum level in BALB/c mice; (C) Bacterial community structure variation at the family level in C57BL/6 mice; (D) Bacterial community structure variation at the family level in BALB/c mice. (E) Taxonomic heatmap of different groups at the genus level. Characteristic relative abundances of various genera present in the Control (C57.Ctrl, BA.Ctrl), Acute phase (C57.AP, BA.AP), and Chronic phase (C57.CP, BA.CP). The portrait and landscape stand for different group and species annotation information, respectively. The left pattern indicates a clustering tree at the level of genus. The above profile displays clustering trees among different groups. Each column represents a unique subject.

For all 47 samples, the most common families were Lachnospiraceae (24.3%), Lactobacillaceae (20.0%), and Bacteroidales_S24-7_group (14.2%) (Figures 2C,D). Ruminococcaceae (6.0%), Verrucomicrobiaceae (6.0%), Enterobacteriaceae (5.7%), Erysipelotrichaceae (4.6%), Desulfovibrionaceae (3.7%), and Bacteroidaceae (2.2%) were subdominant families. The dominant families in the Ctrl, AP, and CP groups of C57BL/6 and BALB/c mice are shown in Figures 2C,D, respectively. Lactobacillaceae and Lachnospiraceae gradually decreased from the Ctrl group to the CP group for both mouse strains. The Bacteroidales_S24-7_group increased in abundance for these two strains and became the most abundant and the top two taxa on day 45 but decreased on day 65. Interestingly, the abundance of Ruminococcaceae changed only slightly from the Ctrl group to the CP group for different mouse strains. Surprisingly, the low abundance of Verrucomicrobiaceae in C57.Ctrl (0.08%) was dramatically increased to 15.43% in C57.AP and subsequently decreased to 3.68% in C57.CP (Figure 2C). For BALB/c mice, the abundance of Verrucomicrobiaceae rapidly increased to 16.43% on day 65 post-infection from 0.07% in BA.AP (Figure 2D).

Hierarchical clustering based on the abundance profile of the genera showed that the two strains of mice tended to group together under the same experimental conditions (Figure 2E). Interestingly, non-infected control, and acute phase groups clustered together, whereas on the left of the heatmap, a separation was observed between the AP and CP groups. At the genus level, several taxa showed significant differences among the six groups. In Figure 2E, the most common genus in each group is shown. The gut microbiota in C57.CP was characterized by higher amounts of Oscillibacter, Helicobacter, Flavonifractor, and Peptoclostridium, and decreased amounts of Lachnospiraceae_NK4A136_group. Compared with BA.Ctrl, OTUs belonging to Bifidobacterium and Erysipelatoclostridium were observed more frequently after infection in BA.AP, whereas Sporosarcina, Staphylococcus, and Lachnospiraceae_UCG-001 were more abundant in the chronic phase BA.CP.

Comparison of Bacterial Community Within Groups

Alpha diversity was calculated, including Chao1, good coverage, observed species, and Shannon index (Table 1). The trends of alpha diversity metrics for gut samples from the Ctrl to CP were different between different mice strains. For C57BL/6 mice, OTU numbers, observed species, and Shannon and Chao1 index values declined from group C57.Ctrl to C57.CP. In contrast, these values increased in BA.AP and finally decreased thereafter in BA.CP. The results showed that the interquartile range of species diversity was increased from the Ctrl to AP and CP in both C57BL/6 and BALB/c mice (Figures 3A,B). Outliers were only detected in group C57.Ctrl, BA.Ctrl, and BA.AP (Figure 3B).

Figure 3.

Figure 3

Bacterial community comparison of different groups between uninfected mice and infected mice. Outliers were plotted as individual points. (A) Alpha diversity analysis based on the Chao1 index among groups in different mouse strains. (B) Alpha diversity analysis based on the observed species index among groups in different mouse strains. (C) Beta diversity analysis based on weighted UniFrac in different mouse strain.

For Chao1 analysis (Figure 3A), C57.Ctrl samples had a significantly higher value than C57.AP and C57.CP (P = 0.046, P = 0.001; Wilcox rank-sum test). For BALB/c mice, BA.AP samples had a significantly higher Chao1 value than BA.Ctrl and BA.CP, respectively (P = 0.044 and P = 0.002, respectively; Wilcox rank-sum test). For observed species analysis (Figure 3B), C57.Ctrl samples had a significantly higher value than C57.CP (P = 0.001; Wilcox rank-sum test). For BALB/c mice, BA.AP samples had a significantly higher value than BA.Ctrl and BA.CP (P = 0.017 and P = 0.001, respectively; Wilcox rank-sum test). For Shannon diversity, a significant difference was only seen between AP and CP samples of BALB/c mice (P = 0.048; Wilcox rank-sum test).

Comparison of Bacterial Community Among Groups

Based on weighted UniFrac (Figure 3C), the beta diversity for gut samples from the Ctrl to CP were similar in both C57BL/6 and BALB/c mice. The values were increased from group C57.Ctrl to C57.CP. Groups C57.AP and C57.CP had a statistically significant increase in beta diversity compared with C57.Ctrl samples (P = 2e-06, P = 1.2e-05; Wilcox rank-sum test). BA.Ctrl samples had a significantly lower beta diversity than BA.AP and BA.CP (P = 0.0001 and P = 2e-06, respectively; Wilcox rank-sum test). This suggested that the range of beta diversity was more heterogeneous in the infected group than in the uninfected control in both C57BL/6 and BALB/c mice. In particular, the degree of dispersion in groups C57.AP and BA.CP was strongly influenced. Outliers were detected in groups C57.Ctrl and BA.Ctrl.

To better visualize the OUT diversity of mouse gut bacteria with a broader evolutionary context in these two strains, a maximum likelihood phylogeny of the top 10 species (relative abundance of OTUs) was constructed. In Figure 4, a total of 101 OTUs were identified as 10 different species. Among these OTUs, 28 were classified as Ruminococcaceae_UCG-014 and 21 as Lachnospirace_NK4A136_group, which were differently distributed in the groups of C57BL/6 and BALB/c mice. Most OTUs occurred in all groups with different abundances.

Figure 4.

Figure 4

Phylogenetic relationships and Species annotation of Operational Taxonomic Units (OTUs). The inner band shows genera colored by OTUs, the next band shows the relative abundance of OTUs, and the outer band shows the annotation reliability distribution of OTUs. Overall abundance and the magnitude of the difference among genera are indicated by bars.

On the PCoA plot, each symbol represents the gut microbiota of one group (Figure 5). It is noteworthy that the microbiotas from the Ctrl group to the CP group were distinct between C57BL/6 and BALB/c mice (Figure 5A). The relationships between community structures revealed by PCoA were further tested by comparing within-group weighted UniFrac distances in C57BL/6 and BALB/c mice (Figure 5B). Consistent with the PCoA plot, the between-group distances were significantly higher than the within-group distances (ANOSIM, MRPP, P ≤ 0.01) for each group (Supplementary Tables 1, 2). These data suggest that the gut microbial community structures between the two strains of mice were significantly different. Additionally, the 47 samples were clustered by UPGMA with an unweighted UniFrac matrix. It showed that C57BL/6 and BALB/c mice were obviously clustered into two independent clusters at the phylum level (Supplementary Figure 4). In each cluster, the main samples in Ctrl, AP, and CP groups were also clustered into subclusters.

Figure 5.

Figure 5

Two-dimensional principal coordinates analysis (PCoA) plot of unweighted (A) and weighted (B) UniFrac distance matrices for both intestinal contents and feces samples from C57BL/6 and BALB/c mice during infection. The bacterial community of the feces and intestinal contents from C57BL/6 mice in group C57.Ctrl, C57.AP, and C57.CP and from BALB/c mice in group BA.Ctrl, BA.AP, and BA.CP are shown. Sample names refer to samples as described in Table 1.

Potential Biomarker Discovery

To identify bacterial taxa that were significantly different between groups of C57BL/6 and BALB/c mice, LEfSe was performed on the taxa. It showed that the bacterial taxa were differentially represented among the different groups of C57BL/6 and BALB/c mice (Figure 6). The potential biomarkers at different taxonomic levels in the groups of C57BL/6 and BALB/c mice were determined (Figure 7). At the genus level, the biomarker with a significant difference between C57.AP and the other two groups in C57BL/6 mice was Akkermansia; the biomarkers showing significant differences between C57.CP and the other two groups in C57BL/6 mice were Helicobacter and Bacteroides. Several genera, including Lactobacillus, Desulfovibrio, and Turicibacter, were associated with the non-infected control in C57BL/6 mice (Figure 6B). In BALB/c mice, bacteria from the genera Bacteroides and Erysipelatoclostridium were identified as markers of BA.AP. The genus Akkermansia was a marker of BA.CP. The genera Lactobacillus and Desulfovibrio were enriched in BA.Ctrl (Figure 6C).

Figure 6.

Figure 6

LEfSe identified the most differentially abundant taxa in different groups of C57BL/6 and BALB/c mice. Only taxa meeting an LDA significance threshold >4 are shown in the figures. (A) Histogram of linear discriminant analysis (LDA) score distribution among the six groups; (B) Histogram of LDA score distribution among three groups of C57BL/6 mice; (C) Histogram of LDA score distribution among three groups of BALB/c mice; (D) Histogram of LDA score distribution between the C57.Ctrl and C57.AP group; (E) Histogram of LDA score distribution between the C57.AP and C57.CP group; (F) Histogram of LDA score distribution between the BA.Ctrl and BA.AP group; (G) Histogram of LDA score distribution between the BA.AP and BA.CP group; (H) Histogram of LDA score distribution between the C57.AP and BA.AP groups. (I) Histogram of LDA score distribution between the C57.CP and BA.CP groups.

Figure 7.

Figure 7

Cladogram of the most differentially abundant taxa in different groups of C57BL/6 and BALB/c mice. (A) Cladogram of the most differentially abundant taxa in six groups of C57BL/6 and BALB/c mice; (B) Cladogram of the most differentially abundant taxa in different groups of C57BL/6 mice; (C) Cladogram of the most differentially abundant taxa in different groups of BALB/c mice; (D) Cladogram of the most differentially abundant taxa between C57.Ctrl and C57.AP; (E) Cladogram of the most differentially abundant taxa between C57.AP and C57.CP; (F) Cladogram of the most differentially abundant taxa between BA.Ctrl and BA.AP; (G) Cladogram of the most differentially abundant taxa between BA.AP and BA.CP; (H) Cladogram of the most differentially abundant taxa between C57.AP and BA.AP; (I) Cladogram of the most differentially abundant taxa between C57.CP and BA.CP.

Discussion

In this study, the gut microbial structure in C57BL/6 and BALB/c mice with S. japonicum ova-induced granulomas was studied. Both species accumulation curves and rarefaction curves gained from the OTU counts approximate the saturation level, indicating a relatively perfect coverage of the total and individual ecosystem diversity. Based on the alpha diversity analysis, we observed that the richness and diversity of the intestinal microbiota in fecal samples from both C57BL/6 and BALB/c mice had been noticeably changed after S. japonicum infection. The beta diversity analysis showed a significantly higher beta diversity in the infected group compared to the uninfected group of these two mouse strains. Consistent with this notion, an overall reduction in alpha diversity and a significant increase in beta diversity were found in the gut microbiota of S. mansoni-infected mice when compared to uninfected controls (Jenkins et al., 2018). A loss of microbial diversity in the intestine is also shown in several human intestinal and extraintestinal disorders, including inflammatory bowel disease (IBD), colorectal cancer (CRC), chronic liver diseases, type 2 diabetes, and asthma (Tilg et al., 2018). In the present study, the core gut microbiome at the phylum level in uninfected and infected mice was dominated by Firmicutes, Bacteroidetes and Proteobacteria, which are commonly found in the mouse model (Zheng et al., 2016a,b; Deng et al., 2018; Kim et al., 2019). Significant differences were found before and after infection. S. japonicum-treated mice had a significantly different microbiome composition compared to control groups of the two mouse strains based on beta diversity analysis. These findings indicated that S. japonicum ova-induced granulomas obviously influenced the microbial composition pattern in mice. This is consistent with a previous study in mice demonstrating the effect of helminth infection on the gut microbiota (Su et al., 2018). However, one study suggested that neither a S. mansoni infection nor praziquantel administration in children triggers a significant effect on the microbial composition, although some subtle modifications in the gut microbiome were observed (Schneeberger et al., 2018). The composition of the gut microbiome, especially in human beings, which is not only influenced by infections, but also by host genetic variation and environmental factors, such as nutrition, may explain this paradox (Kau et al., 2011; Blekhman et al., 2015).

Current data demonstrate that the relative abundance of dominant phyla and families show notable variation during the process of infection. Specifically, S. japonicum infection is connected with a relative decrease of Firmicutes in the feces compared with uninfected C57BL/6 mice. In contrast, S. japonicum cercaria exposure is related to an obvious relative increase of Bacteroidetes and Proteobacteria in the feces compared to untreated C57BL/6 mice. These changes in the abundance of Bacteroidetes and Firmicutes are also detected after human catestatin treatment in C57BL/6 mice (Rabbi et al., 2017). The altered gut microbial composition in mice associated with intestinal inflammation is quite similar to humans with IBD. The patients with IBD also have a comparatively low abundance of Firmicutes and relatively high abundance of Bacteroidetes (Hansen et al., 2010). In the members of the Firmicutes phylum, a loss of Faecalibacterium prausnitzii is correlated with an increased risk of postoperative recurrence of ileal Crohn's disease (Quévrain et al., 2016). In the phylum Bacteroidetes, Bacteroides fragilis toxin is associated with IBD, particularly in patients with active disease (Prindiville et al., 2000). However, the same variations, including the relative abundance of Firmicutes, Bacteroidetes, and Proteobacteria, are not observed in the feces of BALB/c mice. It demonstrates there is a considerable difference in the gut microbiome between the two mouse strains after S. japonicum infection. Moreover, similar results obtained from the PCoA and UPGMA dendrogram demonstrate that the gut microbial community structures after infection were significantly different between C57BL/6 and BALB/c mice. C57BL/6 mice have been a proposed model of S. japonicum schistosomiasis for insight into immunological disease process, such as granulomatous inflammation, due to their high level of inflammatory reactions (Mitchell et al., 1981; Hirata et al., 1993). Thus, C57BL/6 mice may be a useful rodent model for further studies of the schistosomal gut microbiome.

Several high-abundance phyla and families, such as Verrucomicrobia and Enterobacteriaceae, should not be ignored. In several diseases involving inflammation in the gut, including IBD and CRC, Enterobacteriaceae are one of the most commonly overgrown symbiotic bacteria (Zeng et al., 2017). Imbalances in Enterobacteriaceae are associated with IBD and CRC. As a common bacterial phylum detected in soil, Verrucomicrobia is also found in the marine environment (Freitas et al., 2012). However, little is known about its role in the murine gut. To address this issue, the microbial community composition from the S. japonicum infected mice was analyzed. Subsequently, Verrucomicrobia was detected as the dominant bacterial phylum in C57.AP and BA.CP. Consistently, a significant expansion in populations of Verrucomicrobiaceae (species Akkermansia muciniphila) was associated with S. mansoni infection (Jenkins et al., 2018). A similar result was found in humans following wide-spectrum antibiotic treatment (Dubourg et al., 2013). However, the role of this recently characterized phylum remains unclear. The current findings offer more insights into various host intestinal microbiomes after S. japonicum infection and demonstrate that microbiome analysis is potentially powerful for early accurate diagnosis of schistosomiasis and understanding of the pathogenic mechanism of disease progression.

As a broad-spectrum anthelmintic, praziquantel works effectively on cercaria and adult worms and is the recommended drug for schistosomiasis treatment (Mutapi et al., 2017). In conventional treatment, the role of gut microbiome has been ignored. Furthermore, the gut microbiome may disturb treatment by drugs. Additionally, when a drug is unreasonably utilized, drug resistance gradually appears (Vale et al., 2017). Thus, the abundance and composition of schistosomiasis- related bacteria should be evaluated during the treatment process. The results will support the hypothesis that S. japonicum treatment modulates the gut microbiota composition under pathophysiological conditions. In the current study, the gut microbiome was evaluated with 16S rRNA sequencing on a small scale. In addition to bacteria, other microorganisms, including viruses, protists, and fungi, are also considered members of the gut microbiome. Furthermore, the life cycle of S. japonicum, including cercaria, schistosomulum, adults and eggs, is extremely complex. Different stages of S. japonicum will influence the microbiome of the skin, lungs, intestine, and mesentery, which recently has been considered a novel organ (Coffey and O'Leary, 2016). Thus, the sampling time and location will be fully considered in future studies. Moreover, metagenome sequencing for large-scale verification related to matched groups needs to be further validated.

In conclusion, our findings offer an insight into mouse gut microbial modulation after infection with S. japonicum cercaria. We observed an alteration in the gut microbial communities in response to S. japonicum treatment, which is more prominent in C57BL/6 than in BALB/c mice. The microbial community of the intestine could be used as a potential biomarker for the diagnosis of a S. japonicum infection and as an evaluation of the pathogenesis and progression of schistosomiasis.

Ethics Statement

All animal treatments, including use and care, were performed in accordance with the recommendations of the Regulations for the Administration of Affairs Concerning Experimental Animals in China (11/14/1988). The animal experiment was approved by the Animal Research Advisory Committee of the Hubei University of Medicine under permit number HBMU-S20160414 and performed in the Collegial Laboratory Animal Center.

Author Contributions

YZ, SY, BL, ZC, JY, HT, and JL contributed to the study concept and design, analysis and interpretation of data, and drafted the manuscript. YZ, SY, and JL performed the experiments. WL and JW contributed to the analysis and interpretation of data as well as the statistical analysis.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank the staff of the Pathogen biology laboratory and the Collegial Laboratory Animal Center, Hubei University of Medicine, and all participants who contributed snails from the Jiangsu Institute of Parasitic Diseases.

Footnotes

Funding. This work was partially supported by the Special Project for Prevention and Control of Schistosomiasis, Hubei Provincial Health and Family Planning Commission (WJ2017X019), the Foundation for Innovative Research Team of Hubei Provincial Department of Education (T201612), and the Hubei University of Medicine (2014 CXZ02, FDFR201603).

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2019.00352/full#supplementary-material

Supplementary Figure 1

General information regarding uninfected and infected mice. The weights of the body, liver and spleen and spleen size in each group from C57BL/6 and BALB/c mice were obtained.

Supplementary Figure 2

Species diversity and richness evaluation of mouse gut samples during infection. (A) Species accumulation curves. The vertical axis shows the number of observed species that are expected to be found, after sequencing the number of samples shown on the horizontal axis. Curvature toward the horizontal indicates the increased sampling effort required to find species when only rare species remain to be discovered. (B) Rarefaction curves. The vertical axis shows the number of observed species that are expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to find species when only rare species remain to be discovered.

Supplementary Figure 3

Shared operational taxonomic unit (OTU) analysis of the different communities. Venn diagrams showing the unique and shared OTUs in the different groups and communities. Group and sample names refer to groups and samples as described in Table 1.

Supplementary Figure 4

Hierarchical clustering of feces samples by the Unweighted Pair-group Method with Arithmetic Mean (UPGMA) according to their unweighted UniFrac matrix. Bar charts show the relative abundance of the main bacterial phyla found in each of the groups. Phyla representing < 1% of the sequences in a group have been grouped as “other.” Group names refer to groups as described in Table 1.

Supplementary Table 1

Within- vs. Among-Group Dissimilarities analysis by Analysis of Similarities (ANOSIM).

Supplementary Table 2

Within- vs. Among-Group Dissimilarities analysis via Multi Response Permutation Procedure (MRPP).

References

  1. Blekhman R., Goodrich J. K., Huang K., Sun Q., Bukowski R., Bell J. T, et al. (2015). Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 16:191. 10.1186/s13059-015-0759-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen L., Chen Q., Hou W., He L. (2017). High-throughput dynamic analysis of differentially expressed genes in splenic dendritic cells from mice infected with Schistosoma japonicum. Immunol. Lett. 184, 15–22. 10.1016/j.imlet.2017.02.001 [DOI] [PubMed] [Google Scholar]
  3. Coffey J. C., O'Leary D. P. (2016). The mesentery: structure, function, and role in disease. Lancet Gastroenterol. Hepatol. 1, 238–247. 10.1016/S2468-1253(16)30026-7 [DOI] [PubMed] [Google Scholar]
  4. Deng H., Yang S., Zhang Y., Qian K., Zhang Z., Liu Y., et al. (2018). Bacteroides fragilis prevents clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation. Front Microbiol. 9:2976. 10.3389/fmicb.2018.02976 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeSantis T. Z., Hugenholtz P., Larsen N., Rojas M., Brodie E. L., Keller K., et al. (2006). Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069–5072. 10.1128/AEM.03006-05 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dubourg G., Lagier J. C., Armougom F., Robert C., Audoly G., Papazian L., et al. (2013). High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. Int. J. Antimicrob. Agents 41, 149–155. 10.1016/j.ijantimicag.2012.10.012 [DOI] [PubMed] [Google Scholar]
  7. Edgar R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797. 10.1093/nar/gkh340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edgar R. C. (2013). UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996–998. 10.1038/nmeth.2604 [DOI] [PubMed] [Google Scholar]
  9. Edgar R. C., Haas B. J., Clemente J. C., Quince C., Knight R. (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–2200. 10.1093/bioinformatics/btr381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferrari T. C., Moreira P. R. (2011). Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 10, 853–864. 10.1016/S1474-4422(11)70170-3 [DOI] [PubMed] [Google Scholar]
  11. Freitas S., Hatosy S., Fuhrman J. A., Huse S. M., Welch D. B., Sogin M. L., et al. (2012). Global distribution and diversity of marine Verrucomicrobia. ISME J. 6, 1499–1505. 10.1038/ismej.2012.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haas B. J., Gevers D., Earl A. M., Feldgarden M., Ward D. V., Giannoukos G., et al. (2011). Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21, 494–504. 10.1101/gr.112730.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hansen J., Gulati A., Sartor R. B. (2010). The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr. Opin. Gastroenterol. 26, 564–571. 10.1097/MOG.0b013e32833f1195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirata M., Kage M., Takushima M., Fukuma T. (1993). Different courses of granulomatous reactions around Schistosoma japonicum eggs in three strains of mice. J. Parasitol. 79, 266–273. 10.2307/3283517 [DOI] [PubMed] [Google Scholar]
  15. Jenkins T. P., Peachey L. E., Ajami N. J., Macdonald A. S., Hsieh M. H., Brindley P. J., et al. (2018). Schistosoma mansoni infection is associated with quantitative and qualitative modifications of the mammalian intestinal microbiota. Sci. Rep. 8:12072. 10.1038/S41598-018-30412-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kau A. L., Ahern P. P., Griffin N. W., Goodman A. L., Gordon J. I. (2011). Human nutrition, the gut microbiome and the immune system. Nature 474, 327–336. 10.1038/nature10213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kay G. L., Millard A., Sergeant M. J., Midzi N., Gwisai R., Mduluza T., et al. (2015). Differences in the faecal microbiome in Schistosoma haematobium infected children vs. uninfected children. PLoS Negl. Trop. Dis. 9:e0003861. 10.1371/journal.pntd.0003861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kim J. Y., Kim E. M., Yi M. H., Lee J., Lee S., Hwang Y., et al. (2019). Chinese liver fluke Clonorchis sinensis infection changes the gut microbiome and increases probiotic Lactobacillus in mice. Parasitol. Res. 118, 693–699. 10.1007/s00436-018-6179-x [DOI] [PubMed] [Google Scholar]
  19. Magoc T., Salzberg S. L. (2011). FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–2963. 10.1093/bioinformatics/btr507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McManus D. P., Dunne D. W., Sacko M., Utzinger J., Vennervald B. J., Zhou X. N. (2018). Schistosomiasis. Nat. Rev. Dis. Primers 4:13 10.1038/s41572-018-0013-8 [DOI] [PubMed] [Google Scholar]
  21. Mitchell G. F., Garcia E. G., Anders R. F., Valdez C. A., Tapales F. P., Cruise K. M. (1981). Schistosoma japonicum: infection characteristics in mice of various strains and a difference in the response to eggs. Int. J. Parasitol. 11, 267–276. 10.1016/0020-7519(81)90036-9 [DOI] [PubMed] [Google Scholar]
  22. Mutapi F., Maizels R., Fenwick A., Woolhouse M. (2017). Human schistosomiasis in the post mass drug administration era. Lancet Infect. Dis. 17:e42-e48. 10.1016/S1473-3099(16)30475-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Prindiville T., Sheikh R., Cohen S., Tang Y., Cantrell M., Silva J. (2000). Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6, 171–174. 10.3201/eid0602.000210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Quévrain E., Maubert M., Michon C., Chain F., Marquant R., Tailhades J., et al. (2016). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65, 415–425. 10.1136/gutjnl-2014-307649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rabbi M. F., Munyaka P. M., Eissa N., Metz-Boutigue M. H., Khafipour E., Ghia J. E. (2017). Human catestatin alters gut microbiota composition in mice. Front. Microbiol. 7:2151. 10.3389/fmicb.2016.02151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ross A. G., Bartley P. B., Sleigh A. C., Olds G. R., Li Y., Williams G. M., et al. (2002). Schistosomiasis. N. Engl. J. Med. 346, 1212–1220. 10.1056/NEJMra012396 [DOI] [PubMed] [Google Scholar]
  27. Schneeberger P. H., Coulibaly J. T., Panic G., Daubenberger C., Gueuning M., Frey J., et al. (2018). Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome. Parasit. Vectors 11:168. 10.1186/s13071-018-2739-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schwartz C., Fallon P. G. (2018). Schistosoma “eggs-iting” the host: granuloma formation and egg excretion. Front. Immunol. 9:2492. 10.3389/fimmu.2018.02492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Seki T., Kumagai T., Kwansa-Bentum B., Furushima-Shimogawara R., Anyan W. K., Miyazawa Y., et al. (2012). Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica. Infect. Immun. 80, 159–168. 10.1128/IAI.05581-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sickle J. V. (1997). Using mean similarity dendrograms to evaluate classifications. J. Agric. Biol. Environ. Stud. 2, 370–388. 10.2307/1400509 [DOI] [Google Scholar]
  31. Su C., Su L., Li Y., Long S. R., Chang J., Zhang W., et al. (2018). Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis. Mucosal Immunol. 11, 144–157. 10.1038/mi.2017.20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tilg H., Adolph T. E., Gerner R. R., Moschen A. R. (2018). The intestinal microbiota in colorectal cancer. Cancer Cell 33, 954–964. 10.1016/j.ccell.2018.03.004 [DOI] [PubMed] [Google Scholar]
  33. Vale N., Gouveia M. J., Rinaldi G., Brindley P. J., Gärtner F., Correia Da Costa J. M. (2017). Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance. Antimicrob. Agents Chemother. 61:e02582–e02516. 10.1128/AAC.02582-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wang Q., Garrity G. M., Tiedje J. M., Cole J. R. (2007). Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267. 10.1128/AEM.00062-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zeng M., Inohara N., Nuñez G. (2017). Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 10, 18–26. 10.1038/mi.2016.75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zhao Y., Zhang Y., Wang G., Han R., Xie X. (2016). Effects of chlorpyrifos on the gut microbiome and urine metabolome in mouse (Mus musculus). Chemosphere 153, 287–293. 10.1016/j.chemosphere.2016.03.055 [DOI] [PubMed] [Google Scholar]
  37. Zheng J., Xiao X., Zhang Q., Yu M., Xu J., Qi C., et al. (2016a). The effects of maternal and post-weaning diet interaction on glucose metabolism and gut microbiota in male mice offspring. Biosci. Rep. 36:e00341. 10.1042/BSR20160103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zheng J., Xiao X., Zhang Q., Yu M., Xu J., Qi C., et al. (2016b). The programming effects of nutrition-induced catch-up growth on gut microbiota and metabolic diseases in adult mice. Microbiologyopen 5, 296–306. 10.1002/mbo3.328 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure 1

General information regarding uninfected and infected mice. The weights of the body, liver and spleen and spleen size in each group from C57BL/6 and BALB/c mice were obtained.

Supplementary Figure 2

Species diversity and richness evaluation of mouse gut samples during infection. (A) Species accumulation curves. The vertical axis shows the number of observed species that are expected to be found, after sequencing the number of samples shown on the horizontal axis. Curvature toward the horizontal indicates the increased sampling effort required to find species when only rare species remain to be discovered. (B) Rarefaction curves. The vertical axis shows the number of observed species that are expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to find species when only rare species remain to be discovered.

Supplementary Figure 3

Shared operational taxonomic unit (OTU) analysis of the different communities. Venn diagrams showing the unique and shared OTUs in the different groups and communities. Group and sample names refer to groups and samples as described in Table 1.

Supplementary Figure 4

Hierarchical clustering of feces samples by the Unweighted Pair-group Method with Arithmetic Mean (UPGMA) according to their unweighted UniFrac matrix. Bar charts show the relative abundance of the main bacterial phyla found in each of the groups. Phyla representing < 1% of the sequences in a group have been grouped as “other.” Group names refer to groups as described in Table 1.

Supplementary Table 1

Within- vs. Among-Group Dissimilarities analysis by Analysis of Similarities (ANOSIM).

Supplementary Table 2

Within- vs. Among-Group Dissimilarities analysis via Multi Response Permutation Procedure (MRPP).


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES